Global Orally Disintegrating Tablet Market Data Survey Report 2025
SUMMARY
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablet market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The global Orally Disintegrating Tablet market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
- Global market size and forecast
- Regional market size, production data and export & import
- Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
- Average market price by SUK
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- Teva
- Merck
- Mylan
- Pfizer
- Johnson and Johnson
- GSK
- GSK
- Eli Lilly and Company
- AstraZeneca
- Bristol-Myers Squibb
- Conquer
- CNS Diseases
- Gastrointestinal Diseases
- CVS Diseases
- Others
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Teva
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Merck
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mylan
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Pfizer
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Johnson and Johnson
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GSK
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GSK
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Eli Lilly and Company
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 AstraZeneca
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Bristol-Myers Squibb
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Conquer
4 MAJOR APPLICATION
4.1 CNS Diseases
4.1.1 Overview
4.1.2 CNS Diseases Market Size and Forecast
4.2 Gastrointestinal Diseases
4.2.1 Overview
4.2.2 Gastrointestinal Diseases Market Size and Forecast
4.3 CVS Diseases
4.3.1 Overview
4.3.2 CVS Diseases Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Teva
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Merck
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Mylan
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Pfizer
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Johnson and Johnson
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 GSK
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 GSK
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Eli Lilly and Company
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 AstraZeneca
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 Bristol-Myers Squibb
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Conquer
4 MAJOR APPLICATION
4.1 CNS Diseases
4.1.1 Overview
4.1.2 CNS Diseases Market Size and Forecast
4.2 Gastrointestinal Diseases
4.2.1 Overview
4.2.2 Gastrointestinal Diseases Market Size and Forecast
4.3 CVS Diseases
4.3.1 Overview
4.3.2 CVS Diseases Market Size and Forecast
4.4 Others
4.4.1 Overview
4.4.2 Others Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
LIST OF TABLES
Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck
Tab Sales Revenue, Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson and Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Conquer
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
Tab Regional Production 2011-2017 (Million USD)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Million USD)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Million USD)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Million USD)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Million USD)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva
Tab Sales Revenue, Volume, Price, Cost and Margin of Merck
Tab Sales Revenue, Volume, Price, Cost and Margin of Mylan
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Johnson and Johnson
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of GSK
Tab Sales Revenue, Volume, Price, Cost and Margin of Eli Lilly and Company
Tab Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Tab Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Tab Sales Revenue, Volume, Price, Cost and Margin of Conquer
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
LIST OF FIGURES
Fig Global Orally Disintegrating Tablet Market Size and CAGR 2011-2017 (Million USD)
Fig Global Orally Disintegrating Tablet Market Size and CAGR 2011-2017 (Volume)
Fig Global Orally Disintegrating Tablet Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Orally Disintegrating Tablet Market Forecast and CAGR 2018-2025 (Volume)
Fig CNS Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig CNS Diseases Market Size and CAGR 2011-2017 (Volume)
Fig CNS Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig CNS Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig Gastrointestinal Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig Gastrointestinal Diseases Market Size and CAGR 2011-2017 (Volume)
Fig Gastrointestinal Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig Gastrointestinal Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig CVS Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig CVS Diseases Market Size and CAGR 2011-2017 (Volume)
Fig CVS Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig CVS Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Fig Global Orally Disintegrating Tablet Market Size and CAGR 2011-2017 (Million USD)
Fig Global Orally Disintegrating Tablet Market Size and CAGR 2011-2017 (Volume)
Fig Global Orally Disintegrating Tablet Market Forecast and CAGR 2018-2025 (Million USD)
Fig Global Orally Disintegrating Tablet Market Forecast and CAGR 2018-2025 (Volume)
Fig CNS Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig CNS Diseases Market Size and CAGR 2011-2017 (Volume)
Fig CNS Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig CNS Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig Gastrointestinal Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig Gastrointestinal Diseases Market Size and CAGR 2011-2017 (Volume)
Fig Gastrointestinal Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig Gastrointestinal Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig CVS Diseases Market Size and CAGR 2011-2017 (Million USD)
Fig CVS Diseases Market Size and CAGR 2011-2017 (Volume)
Fig CVS Diseases Market Forecast and CAGR 2018-2025 (Million USD)
Fig CVS Diseases Market Forecast and CAGR 2018-2025 (Volume)
Fig Others Market Size and CAGR 2011-2017 (Million USD)
Fig Others Market Size and CAGR 2011-2017 (Volume)
Fig Others Market Forecast and CAGR 2018-2025 (Million USD)
Fig Others Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
